Tesofensine
id:
tesofensine-171-3672529
title:
Tesofensine
text:
Tesofensine (NS2330) is a serotonin–noradrenaline–dopamine reuptake inhibitor from the phenyltropane family of drugs, which is being developed for the treatment of obesity. Tesofensine was originally developed by a Danish biotechnology company, NeuroSearch, who transferred the rights to Saniona in 2014. As of 2019, tesofensine has been discontinued for the treatment of Alzheimer's and Parkinson's disease but is in phase III clinical trial for obesity.
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Tesofensine
date created:
2007-09-08T09:39:58Z
date modified:
2024-09-01T11:11:30Z
main entity:
{"identifier":"Q7705544","url":"https://www.wikidata.org/entity/Q7705544"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/a/a4/Tesofensine_chemical_structure.png","width":1782,"height":1013}
fields total:
13
integrity:
16